Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021

D. Banerjee, P. Winocour, T. A. Chowdhury, P. De, M. Wahba, R. Montero, D. Fogarty, A. H. Frankel, J. Karalliedde, P. B. Mark, D. C. Patel, A. Pokrajac, A. Sharif, S. Zac-Varghese, S. Bain, I. Dasgupta, Unknown

Open source

DOI: 10.1186/s12882-021-02587-5
Published: 2022-01-03
Container: BMC Nephrology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12882-021-02587-5,
  title = {Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021},
  author = {D. Banerjee and P. Winocour and T. A. Chowdhury and P. De and M. Wahba and R. Montero and D. Fogarty and A. H. Frankel and J. Karalliedde and P. B. Mark and D. C. Patel and A. Pokrajac and A. Sharif and S. Zac-Varghese and S. Bain and I. Dasgupta and Unknown},
  year = {2022},
  journal = {BMC Nephrology},
  doi = {10.1186/s12882-021-02587-5},
  url = {https://doi.org/10.1186/s12882-021-02587-5}
}

RIS

TY  - JOUR
TI  - Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021
AU  - D. Banerjee
AU  - P. Winocour
AU  - T. A. Chowdhury
AU  - P. De
AU  - M. Wahba
AU  - R. Montero
AU  - D. Fogarty
AU  - A. H. Frankel
AU  - J. Karalliedde
AU  - P. B. Mark
AU  - D. C. Patel
AU  - A. Pokrajac
AU  - A. Sharif
AU  - S. Zac-Varghese
AU  - S. Bain
AU  - I. Dasgupta
AU  - Unknown
PY  - 2022
JO  - BMC Nephrology
DO  - 10.1186/s12882-021-02587-5
UR  - https://doi.org/10.1186/s12882-021-02587-5
ER  -

APA

Banerjee, D., Winocour, P., Chowdhury, T. A., De, P., Wahba, M., Montero, R., Fogarty, D., Frankel, A. H., Karalliedde, J., Mark, P. B., Patel, D. C., Pokrajac, A., Sharif, A., Zac-Varghese, S., Bain, S., Dasgupta, I., & Unknown (2022). Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021. BMC Nephrology. https://doi.org/10.1186/s12882-021-02587-5

Source records

crossref · retrieved 2026-09-26T22:09:38.934Z